MAIA Biotechnology (MAIA) news
Recent news
Maia Biotechnology - May offer securities up to $150 mln - SEC filing
MAIA Biotechnology, Inc. (NYSE American: MAIA) has announced a public offering of up to $30 million in common stock, with the potential for additional $4.5 million in shares through a 45-day over-allotment option. The offering includes 20,000,000 shares priced at $1.50 per share, with the…
AInvest Wire · Aug 21, 2026Maia Biotechnology announces open market purchases by CEO and director
MAIA Biotechnology, Inc. (NYSE American: MAIA) announced that its CEO and certain members of the Board of Directors purchased a total of 182,445 shares of the company’s common stock in open market transactions between November 21 and 28, 2025. The average price per share was $1.06 during the…
AInvest Wire · Jun 2, 2026ImportantMaia Biotechnology shares surged 27% after the company reveals new data showing Thio’s potent anticancer activity in aggressive pediatric brain cancer
AInvest Wire · Oct 12, 2023ImportantMAIA Biotechnology Reveals New Data Showing THIO’s Potent Anticancer Activity in Aggressive Pediatric Brain Cancer
AInvest Wire · Oct 12, 2023Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.